Merdury Biopharmaceutical Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	53.17	68.01	44.29	31.94	2.56
Short-Term Investments	110.6	162.8	284.78	108.7	-
Cash & Short-Term Investments	163.77	230.81	329.07	140.64	2.56
Cash Growth	-29.05%	-29.86%	133.99%	5391.45%	2877.91%
Other Receivables	6.38	4.73	0.23	2.46	-
Receivables	6.38	4.73	0.23	2.46	-
Prepaid Expenses	4.25	7.18	10.07	2.64	-
Other Current Assets	0.36	0.18	0.55	-	1.37
Total Current Assets	174.76	242.9	339.93	145.73	3.93
Property, Plant & Equipment	89.75	94.41	79.94	75.15	8.46
Other Intangible Assets	5.45	4.53	2.71	0.5	0.49
Other Long-Term Assets	8.44	11.37	15.5	8.55	0.51
Total Assets	278.39	353.2	438.08	229.93	13.38
Accrued Expenses	7.99	7.21	-	4.61	0.66
Current Portion of Long-Term Debt	2.12	1.21	-	-	-
Current Portion of Leases	0.73	2.6	0.68	1.05	0.79
Current Unearned Revenue	5.79	5.48	0.44	-	-
Other Current Liabilities	3.14	2.73	6.93	1.57	0.26
Total Current Liabilities	19.77	19.24	8.05	7.23	1.7
Long-Term Debt	38.1	40.39	41.6	41.6	-
Long-Term Leases	0.85	3.31	0.07	0.77	1.22
Total Liabilities	58.72	62.93	49.72	49.6	2.93
Common Stock	106.74	105.46	103.99	100.87	15.4
Additional Paid-In Capital	244.5	291.29	328.17	110.72	0.37
Retained Earnings	-67.23	-50.57	-43.82	-31.25	-5.31
Treasury Stock	-64.81	-56.24	-	-	-
Comprehensive Income & Other	0.46	0.33	0.01	-	-
Shareholders' Equity	219.67	290.27	388.35	180.33	10.46
Total Liabilities & Equity	278.39	353.2	438.08	229.93	13.38
Total Debt	41.79	47.51	42.35	43.42	2.01
Net Cash (Debt)	121.98	183.3	286.73	97.21	0.55
Net Cash Growth	-33.45%	-36.07%	194.94%	17575.09%	-
Net Cash Per Share	0.29	0.44	0.72	0.26	0.00
Filing Date Shares Outstanding	422.03	421.85	415.96	403.46	403.46
Total Common Shares Outstanding	422.03	421.85	415.96	403.46	307.94
Working Capital	154.99	223.66	331.88	138.5	2.22
Book Value Per Share	0.52	0.69	0.93	0.45	0.03
Tangible Book Value	214.22	285.75	385.65	179.83	9.97
Tangible Book Value Per Share	0.51	0.68	0.93	0.45	0.03
Land	41.9	41.9	-	41.9	-
Buildings	18.2	18.27	-	18.12	-
Machinery	34.42	23.45	-	6.42	5.88
Construction In Progress	7.29	11.59	-	7.5	-
Leasehold Improvements	2.36	2.33	-	0.91	0.91

Source: S&P Global Market Intelligence. Standard template. Financial Sources.